BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23549425)

  • 1. Poly-ADP-ribose-polymerase inhibition ameliorates hind limb ischemia reperfusion injury in a murine model of type 2 diabetes.
    Long CA; Boulom V; Albadawi H; Tsai S; Yoo HJ; Oklu R; Goldman MH; Watkins MT
    Ann Surg; 2013 Dec; 258(6):1087-95. PubMed ID: 23549425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postischemic poly (ADP-ribose) polymerase (PARP) inhibition reduces ischemia reperfusion injury in a hind-limb ischemia model.
    Crawford RS; Albadawi H; Atkins MD; Jones JE; Yoo HJ; Conrad MF; Austen WG; Watkins MT
    Surgery; 2010 Jul; 148(1):110-8. PubMed ID: 20132957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyadenosine diphosphate-ribose polymerase inhibition modulates skeletal muscle injury following ischemia reperfusion.
    Hua HT; Albadawi H; Entabi F; Conrad M; Stoner MC; Meriam BT; Sroufe R; Houser S; Lamuraglia GM; Watkins MT
    Arch Surg; 2005 Apr; 140(4):344-51; discussion 351-2. PubMed ID: 15837884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly adenosine diphosphate-ribose polymerase inhibitor PJ34 abolishes systemic proinflammatory responses to thoracic aortic ischemia and reperfusion.
    Black JH; Casey PJ; Albadawi H; Cambria RP; Watkins MT
    J Am Coll Surg; 2006 Jul; 203(1):44-53. PubMed ID: 16798486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local administration of the Poly ADP-Ribose Polymerase (PARP) inhibitor, PJ34 during hindlimb ischemia modulates skeletal muscle reperfusion injury.
    Conrad MF; Albadawi H; Stone DH; Crawford RS; Entabi F; Watkins MT
    J Surg Res; 2006 Oct; 135(2):233-7. PubMed ID: 16872633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PJ34, a poly-ADP-ribose polymerase inhibitor, modulates renal injury after thoracic aortic ischemia/reperfusion.
    Stone DH; Al-Badawi H; Conrad MF; Stoner MC; Entabi F; Cambria RP; Watkins MT
    Surgery; 2005 Aug; 138(2):368-74. PubMed ID: 16153449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(ADP-ribose) Polymerase (PARP) is Critically Involved in Liver Ischemia/Reperfusion-injury.
    Haga S; Kanno A; Morita N; Jin S; Matoba K; Ozawa T; Ozaki M
    J Surg Res; 2022 Feb; 270():124-138. PubMed ID: 34656890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment of therapeutic cells with poly(ADP-ribose) polymerase inhibitor enhances their efficacy in an in vitro model of cell-based therapy in myocardial infarct.
    Szepes M; Janicsek Z; Benkő Z; Cselenyák A; Kiss L
    Int J Mol Med; 2013 Jan; 31(1):26-32. PubMed ID: 23165319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(adenosine diphosphate ribose) polymerase inhibition modulates spinal cord dysfunction after thoracoabdominal aortic ischemia-reperfusion.
    Casey PJ; Black JH; Szabo C; Frosch M; Albadawi H; Chen M; Cambria RP; Watkins MT
    J Vasc Surg; 2005 Jan; 41(1):99-107. PubMed ID: 15696051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PARP inhibitor PJ34 ameliorates cognitive impairments induced by transient cerebral ischemia/reperfusion through its anti-inflammatory effects in a rat model.
    Jiao Y; Li G
    Neurosci Lett; 2021 Nov; 764():136202. PubMed ID: 34478817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced hind limb ischemia-reperfusion injury in Toll-like receptor-4 mutant mice is associated with decreased neutrophil extracellular traps.
    Oklu R; Albadawi H; Jones JE; Yoo HJ; Watkins MT
    J Vasc Surg; 2013 Dec; 58(6):1627-36. PubMed ID: 23683381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of poly(ADP-ribose) polymerase attenuates lung tissue damage after hind limb ischemia-reperfusion in rats.
    Koksel O; Yildirim C; Cinel L; Tamer L; Ozdulger A; Bastürk M; Degirmenci U; Kanik A; Cinel I
    Pharmacol Res; 2005 May; 51(5):453-62. PubMed ID: 15749460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PARP-1 inhibitor alleviates cerebral ischemia/reperfusion injury by reducing PARylation of HK-1 and LDH in mice.
    Chen YL; Wang Y; Fang QY; Wang T; Chen C; Gao TY; Wu M; Zhang WP; Lu YB
    Eur J Pharmacol; 2024 Mar; 967():176377. PubMed ID: 38346469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PJ34, a poly-ADP-ribose polymerase inhibitor, modulates visceral mitochondrial activity and CD14 expression following thoracic aortic ischemia-reperfusion.
    Stone DH; Albadawi H; Conrad MF; Entabi F; Stoner MC; Casey PJ; Cambria RP; Watkins MT
    Am J Surg; 2009 Aug; 198(2):250-5. PubMed ID: 19268911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The poly(adenosine diphosphate-ribose) polymerase inhibitor PJ34 reduces pulmonary ischemia-reperfusion injury in rats.
    Hatachi G; Tsuchiya T; Miyazaki T; Matsumoto K; Yamasaki N; Okita N; Nanashima A; Higami Y; Nagayasu T
    Transplantation; 2014 Sep; 98(6):618-24. PubMed ID: 25221900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective Functions of PJ34, a Poly(ADP-ribose) Polymerase Inhibitor, Are Related to Down-Regulation of Calpain and Nuclear Factor-κB in a Mouse Model of Traumatic Brain Injury.
    Tao X; Chen X; Hou Z; Hao S; Liu B
    World Neurosurg; 2017 Nov; 107():888-899. PubMed ID: 28642177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(ADP-Ribose) polymerase inhibition reduces reperfusion injury after heart transplantation.
    Szabó G; Bährle S; Stumpf N; Sonnenberg K; Szabó E E; Pacher P; Csont T; Schulz R; Dengler TJ; Liaudet L; Jagtap PG; Southan GJ; Vahl CF; Hagl S; Szabó C
    Circ Res; 2002 Jan; 90(1):100-6. PubMed ID: 11786525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BGP-15, a nicotinic amidoxime derivate protecting heart from ischemia reperfusion injury through modulation of poly(ADP-ribose) polymerase.
    Szabados E; Literati-Nagy P; Farkas B; Sumegi B
    Biochem Pharmacol; 2000 Apr; 59(8):937-45. PubMed ID: 10692558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly-ADP-ribose polymerase inhibition enhances ischemic and diabetic wound healing by promoting angiogenesis.
    Zhou X; Patel D; Sen S; Shanmugam V; Sidawy A; Mishra L; Nguyen BN
    J Vasc Surg; 2017 Apr; 65(4):1161-1169. PubMed ID: 27288104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.
    Abdelkarim GE; Gertz K; Harms C; Katchanov J; Dirnagl U; Szabó C; Endres M
    Int J Mol Med; 2001 Mar; 7(3):255-60. PubMed ID: 11179503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.